register now
get brochure
sponsors
add event to diary
email this to...

 

conference details

 
 
 
Commercial and development opportunities for Big Pharma, biotech,
investors and research organisations
 
The World's largest commercial stem cells and regenerative medicine event
 
Now in its 4th year, the annual World Stem Cells & Regenerative Medicine Congress is the world's largest and most influential event to address the commercialisation of stem cells and regenerative medicines. 
 
 
Featuring the most influential and innovative industry and business
leaders this lively and energetic meeting combines expert speakers, cutting-edge case studies and dedicated networking in a deal-making environment where debate is encouraged and discussion thrives.
 
Over three days— the congress will cover both the use of stem cells in drug discovery and development and in regenerative medicine, with a high and significant level of involvement
from Big Pharma this year.
 

7 reasons to attend the World Stem Cells & Regenerative Medicine Congress 2009
1. Big Pharma representation that
represents a huge shift in the field
Big Pharma are beginning to invest heavily
in stem cell technology and regenerative
medicine. Hear about their current
thoughts activities and plans for the future
 
» See the full programme

2. Highest level of speakers delivering
knowledge and insights unavailable
elsewhere
We have more CEO’s on our speaker
platform than most other conferences
have in the audience
 
» See the full speaker list
 
3. Go beyond solid research and good
science and into the market
Discover first-hand how regenerative
medicine and stem cell technologies are
being utilised in house and taken to market
 
4. Covering both application classes of
stem cell technology
Addressing therapeutic and nontherapeutic
application of stem cell technology, in both drug development/discovery and regenerative medicineu won’t attend another vaccine congress in 2009 with more C-level representatives
 
» Register now
 
5. Groundbreaking and innovative content that tackles the issues that matter
Congress participants are not afraid to be
controversial and to challenge. Attend a
congress where the issues that matter are
addressed by the people making it happen
 
» See the full speaker line up

6. Unparalleled opportunities to build and broker relationships
An attendee list that reads like an industry
who’s who. Ensure you are on that list

7. This is the world’s leading congress to address the commercial application of
stem cell technology and regenerative
medicine
The most productive 3 days you will spend
out of your office in 2009
 
» Find out more about sponsorship
 
 
  OUR SPEAKERS  
 
Paul Ekman, Phd
DR RUTH MCKERNAN
Chief Scientific Officer, Pfizer Regenerative Medicine
Thupten Jinpa, PhD
DR HUSEYIN MEHMET
Director, Apostosis,
Merck


Robina Courtin
DR OLE D MADSEN
Research Director,
Novo Nordisk

Owen Flanagan, PhD
DR GABRIELA GEBRIN CEZAR
Assistant Professor, Stem Cell Safety Laboratory, University of Wisconsin Madison

Andre Smith
DR LYNN HOFFMAN
Chief Executive Officer and Chief Scientific Officer, Stratatech Corporation

Dacher Keltner, PhD
DR ED BAETGE
Chief Scientific Officer,
Novocell

Lawrence Rose
DR MIRIAM BIBEL
Senior Researcher, Neurodegeneration Department, Novartis Institute for Biomedical Research

Pam Moore
DR GREGORY BONFIGLIO
Managing Partner,
Proteus Venture Partners
 
Pam Moore
DR BERNARD SIEGEL
Founder and Executive Director, Genetics Policy Institute
 

 
Robert Sapolsky, PhD
DR ALAN TROUNSON
President, California Institute for Regenerative Medicine

David Spiegel, PhD
DR RANDAL MILLS
Chief Executive Officer,
Osiris

Monica Broecker
DR AJAN REGINALD
Global Head of Emerging  Technologies, Roche

Melissa Mathison
DR TIM ALLSOPP
Chief Scientific Officer,
Stem Cell Sciences

Urs Steiner Leonhardt
DR MICHAEL SIANI-ROSE
President and Founder, Theregen

James R. Doty, MD, FAC
DR NICK HIGGINS
Chief Executive Officer and Executive Director, Intercytex

Darrin McMahon, PhD
DR CHRIS MASON
Director, Regenerative Medicine Bioprocessing Unit,
University College London

William Andereck
DR JOHN MCNEISH
VExecutive Director, Regenerative Medicine,
Pfizer

 Pam Moore
DR DAVID SMITH
Head of Cell Therapy,
Lonza
 
  
Anne Harrington, PhD
DR DAVID AMRANI
Senior Director and Head Regenerative Medicine and Stem Cells R&D, Baxter

Chade-Meng Tan
DR AARAON CHUANG
Scientific Director, GlaxoSmithKline

B. Alan Wallace, PhD
DR GEOFF MACKAY
Chief Executive Officer, Organogenesis

Corey Keyes, PhD
DR CHIKAFUMI YOKOYAMA
Chief Executive Officer,  
ReproCELL

Ross Mirkarimi, MSc
DR PHILIPPE MENASCHE
Director, Cell Therapy in Cardiovascular Diseases Research Unit, Hospital European Georges Pompidou

Pamela Cayton
DR AVINOAM KADOURI
Chief Executive Officer, 
Rainbow Biotechnologies

Lawrence Rose
DR MAHENDRA RAO
Vice President of R&D, Primary and Stem Cell Systems, Invitrogen Corporation 

Pam Moore
DR DOUG SIPP
Manager, Scientific Communication and International Affairs,
Riken Center for Developmental Biology
 
 
  
 
Who's attending?

Error processing SSI file

 
 

event sponsors
 Gold:
› See full list of sponsors

 
 
sponsorship opportunities
Grow your business - sponsorship really works!
  • Get cost effective marketing exposure and branding to your target audience, culminating in face-to-face meetings with your top prospects
  • Position yourself as an industry leader
  • Increase your brand recognition
  • Create new partnerships and alliances
  • Showcase products and services to a targeted audience of decision-makers 
 
Target your market!
 
For details contact
Sylvester Gabriel or call +44 (0)20 7827 5994

Get sponsor pack